BioCentury
ARTICLE | Politics, Policy & Law

NIH poised to decide on march-in petition

House Democrats urge the Biden administration to march-in on Xtandi patents

February 10, 2022 2:42 AM UTC

Days ahead of an expected decision on a petition requesting that NIH exercise “march-in” rights to patents on prostate cancer drug Xtandi from Astellas, a dozen House Democrats have ...



Access this Article